Atlas Trials

MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

Clinical trial NCT00326456 · UNKNOWN

Trial details

NCT number
NCT00326456
Sponsor
National Cancer Institute, Naples
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Ovarian Cancer
Start date
2003-01-01
Primary completion
2023-12-01
Enrollment
820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.